Lemme claims that the product acts to "promote GLP-1 production," reduce hunger and cravings," "promote fat reduction and healthy weight management" on the basis of "three clinically-studied ingredients." If Lemme argues in a motion to dismiss or its Answer that the case should be barred because a private consumer cannot bring a lawsuit based on lack of adequate substantiation, the plaintiffs may argue that "clinically studied" implies "clinically proven" or "clinically shown" and, therefore, may convey that the product has the level of support touted in the advertising
Ozempic (semaglutide) is a prescription medication administered once weekly as a subcutaneous injection
See our Privacy Policy on our contact page for more information
These structural differences could influence how each compound interacts with metabolic signaling pathways within research environments
doi: 10.4239/wjd.v9.i7.132
Serious risks are less common but include pancreatitis and, based on animal studies, a theoretical risk of thyroid C-cell tumors, which is why GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma
